PDS Biotech Announces Abstract Accepted for Oral Presentation at 2024 ASTRO Annual Meeting
August 08, 2024 08:00 ET
|
PDS Biotechnology Corporation
PRINCETON, N.J., Aug. 08, 2024 (GLOBE NEWSWIRE) -- PDS Biotechnology Corporation (Nasdaq: PDSB) (“PDS Biotech” or the “Company”), a late-stage immunotherapy company focused on transforming how the...
Aveanna Healthcare Holdings Announces Second Quarter 2024 Financial Results and Revised 2024 Outlook
August 08, 2024 06:30 ET
|
Aveanna Healthcare Holdings, Inc
Second Quarter Revenue was $505.0 million, a 7.0% increase over the prior year Gross margin increased 1.9% to $158.3 million, compared to Q2 2023 Second Quarter Net income was $13.9 million,...
PDS Biotech to Announce Second Quarter Financial Results on August 13, 2024
August 07, 2024 08:00 ET
|
PDS Biotechnology Corporation
PRINCETON, N.J., Aug. 07, 2024 (GLOBE NEWSWIRE) -- PDS Biotechnology Corporation (Nasdaq: PDSB) (“PDS Biotech” or the “Company”), a late-stage immunotherapy company focused on transforming how the...
PDS Biotech Announces Abstract Accepted for Presentation at ESMO Congress 2024
August 05, 2024 08:00 ET
|
PDS Biotechnology Corporation
PRINCETON, N.J., Aug. 05, 2024 (GLOBE NEWSWIRE) -- PDS Biotechnology Corporation (Nasdaq: PDSB) (“PDS Biotech” or the “Company”), a late-stage immunotherapy company focused on transforming how the...
Flexera Announces Winners of the 2024 Technology Intelligence Awards
August 01, 2024 09:00 ET
|
Flexera
ITASCA, Ill., Aug. 01, 2024 (GLOBE NEWSWIRE) -- Flexera, the global leader in Technology Intelligence, today announces the winners of the fourth annual Technology Intelligence Awards. The awards...
PDS Biotech Aligns with FDA on Phase 3 Trial in HPV16-Positive First-Line Recurrent or Metastatic Head and Neck Cancer
August 01, 2024 07:45 ET
|
PDS Biotechnology Corporation
Company to initiate Phase 3 VERSATILE-003 trial in Q4 2024 Conference Call Today at 8:00 a.m. Eastern Time PRINCETON, N.J., Aug. 01, 2024 (GLOBE NEWSWIRE) -- PDS Biotechnology Corporation...
PDS Biotech to Host Clinical Program Update Conference Call on August 1, 2024, at 8 a.m. Eastern Time
July 31, 2024 16:01 ET
|
PDS Biotechnology Corporation
PRINCETON, N.J., July 31, 2024 (GLOBE NEWSWIRE) -- PDS Biotechnology Corporation (Nasdaq: PDSB) (“PDS Biotech” or the “Company”), a late-stage immunotherapy company focused on transforming how the...
Precision Drilling Announces 2024 Second Quarter Unaudited Financial Results
July 30, 2024 16:30 ET
|
Precision Drilling Corporation
CALGARY, Alberta, July 30, 2024 (GLOBE NEWSWIRE) -- This news release contains “forward-looking information and statements” within the meaning of applicable securities laws. For a full disclosure of...
PDS Biotech to Participate at BTIG Virtual Biotechnology Conference
July 29, 2024 08:00 ET
|
PDS Biotechnology Corporation
PRINCETON, N.J., July 29, 2024 (GLOBE NEWSWIRE) -- PDS Biotechnology Corporation (Nasdaq: PDSB) (“PDS Biotech” or the “Company”), a late-stage immunotherapy company focused on transforming how the...
Matereal Inc. Raises $4.5M Seed Round, To Lead the Fight Against Toxic Plastics
July 25, 2024 09:00 ET
|
Matereal
Matereal closes $4.5 million seed funding round to commercialise their non isocyanate polyurethane (NIPU) chemical platform Polaris™.